Showing results (111-120 of 283) with videos related to
Sort By:
Pageof 29
Biochimica Et Biophysica Acta|January 27, 2009
Identification of nuclear localization and nuclear export signals in Ets2, and the transcriptional regulation of Ets2 and CTP:phosphocholine cytidylyltransferase alpha in tetradecanoyl-13-acetate or macrophage-colony stimulating factor stimulated RAW264 cellsKoichi Okamura, Satoko Yamashita, Hiromi Ando, et al.Surgery|October 28, 2015
Comparison of the international consensus guidelines for predicting malignancy in intraductal papillary mucinous neoplasmsSuguru Yamada, Tsutomu Fujii, Kenta Murotani, et al.Journal of Surgical Oncology|April 22, 2016
S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical modelMasaya Suenaga, Suguru Yamada, Tsutomu Fujii, et al.Journal of Hepato-Biliary-Pancreatic Sciences|August 2, 2014
Hepatectomy for hepatocellular carcinoma in patients with hemophiliaYoshikuni Inokawa, Hiroyuki Sugimoto, Mitsuro Kanda, et al.Journal of Hepato-Biliary-Pancreatic Sciences|May 15, 2014
Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resectionKazuo Yamamura, Hiroyuki Sugimoto, Mitsuro Kanda, et al.Hepato-Gastroenterology|December 2, 2014
Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomyYukiko Niwa, Masahiko Koike, Naoki Iwata, et al.International Journal of Surgery (London, England)|May 8, 2016
Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resectionNorimitsu Yabusaki, Tsutomu Fujii, Suguru Yamada, et al.International Journal of Oncology|March 29, 2017
Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinomaTomonari Asano, Suguru Yamada, Bryan C Fuchs, et al.Medicine|July 22, 2016
The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the analysis of clinicopathological factors influencing relative dose intensityNorimitsu Yabusaki, Tsutomu Fujii, Suguru Yamada, et al.Molecular Carcinogenesis|January 27, 2011
Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinomaMitsuro Kanda, Shuji Nomoto, Yukiyasu Okamura, et al.Pageof 29